Catecholamine metabolism in Gilles de la Tourette's syndrome.
Abnormal central catecholamine neurotransmission has been suggested in Gilles de la Tourette's syndrome. The authors evaluated the sympathetic nervous system in both the basal state and in its responsivity to postural and exercise stress. Plasma norepinephrine and the activities of its synthetic and degradative enzymes were not different in 33 Tourette patients, a control group of unaffected relatives, and another control group of unrelated healthy volunteers. This finding suggests that these patients have neither a generalized dysfunction of norepinephrine metabolism nor a defect in the central control of sympathetic function.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D001792:Blood Platelets / Q000201:enzymology; D002394:Catechol O-Methyltransferase / Q000097:blood; D004299:Dopamine beta-Hydroxylase / Q000097:blood; D004912:Erythrocytes / Q000201:enzymology; D005190:Family; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008995:Monoamine Oxidase / Q000097:blood; D009638:Norepinephrine / Q000097:blood*; D005082:Physical Exertion; D011187:Posture; D012737:Sex Factors; D005879:Tourette Syndrome / Q000097:blood* / Q000188:drug therapy / Q000201:enzymology
D004299:Dopamine beta-Hydroxylase; D008995:Monoamine Oxidase; D002394:Catechol O-Methyltransferase; D006220:Haloperidol; D009638:Norepinephrine